ThePeptide
CJC-1295 + Ipamorelin 10mg
CJC-1295 + Ipamorelin 10mg
Couldn't load pickup availability
⚠️ Under no circumstances should any products be used without the express direction of a licensed physician.
Each vial contains a blend of 5mg CJC-1295 and 5mg Ipamorelin (10mg total).
This pre-mixed research blend combines two growth hormone secretagogues studied together for their complementary mechanisms on GH pulsatility in preclinical research settings.
CJC-1295 (No DAC) Research Profile
A synthetic GHRH analogue studied for its ability to stimulate pulsatile growth hormone release in animal models, with an approximate half-life of 30 minutes in research settings.
Ipamorelin Research Profile
A selective GH secretagogue and ghrelin receptor agonist studied for its high selectivity, with minimal observed effect on cortisol or prolactin compared to other secretagogues.
For use by qualified researchers in controlled laboratory settings only.
Add 2mL of bacteriostatic water to get a solution that is 5mg/mL, such that every 0.1mL (10 units on an insulin syringe) is equal to 0.5mg (500mcg) of the blend.
- Lyophilized (unreconstituted): Store at −20°C. Stable for 24+ months when sealed.
- After reconstitution: Refrigerate at 2–8°C. Use within 28 days.
- Light & heat: Protect from direct light and heat at all times.
- Do not freeze reconstituted solution. Freeze-thaw cycles degrade peptide integrity.
- CJC-1295 (No DAC): 5mg per vial
- Ipamorelin: 5mg per vial
- Total content: 10mg blend
- Form: Lyophilized powder blend in sterile vial
- Purity: ≥99% (HPLC verified)
| Test | Method | Result |
|---|---|---|
| Identity | LC-MS/MS | Confirmed ✓ |
| Purity (HPLC) | HPLC-UV | ≥99% ✓ |
| Appearance | Visual | White lyophilized powder ✓ |
| Endotoxin | LAL method | <1 EU/mg ✓ |
| Heavy metals | ICP-MS | Pass ✓ |
| Sterility | USP <71> | Pass ✓ |
Independent third-party testing by Janoshik Analytical. Full batch reports available on our lab results page.
Peer-reviewed publications for research reference only.
- BPC-157 — repair and recovery peptide
- Semaglutide (Ozempic / Wegovy) — GLP-1 receptor agonist
- Tirzepatide (Mounjaro / Zepbound) — dual GIP/GLP-1 receptor agonist
- Retatrutide (Triple Agonist) — next-gen triple agonist
Not for human or animal use. This product must not be administered to, consumed by, or used on humans or animals under any circumstances.
By purchasing this product, you confirm that you are a qualified researcher, that you will use this product solely for lawful in-vitro research purposes, and that you accept full responsibility for compliance with all applicable regulations.
For research purposes only. Not for human consumption.
Share
